Capital City Trust’s Sanofi SNY Stock Holding History

Capital City Trust’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-180	Closed	-$9K	–	181
2013 Q2	$9K	Buy	+180	New	+$9.59K	﹤0.01%	180

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Montag & Caldwell Atlanta, Georgia $457M AUM 20.19% 1-Year Est. Return

NIMC

NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Capital City Trust's SNY Position: Q3 2013 in Review

Capital City Trust sold out of Sanofi (SNY) in Q3 2013, closing a stake of 180 shares — an estimated $9K sold.

Capital City Trust first reported a position in SNY in Q2 2013 and held it in 1 quarter. The position peaked at $9K in Q2 2013. 456 funds tracked by Wall St. Rank hold SNY as of Q3 2013.

Capital City Trust reported no remaining Sanofi position as of Q3 2013 after selling out during the quarter.
Capital City Trust sold 180 Sanofi shares in Q3 2013, an estimated $9K.
Capital City Trust first reported a position in Sanofi in Q2 2013 and held it in 1 quarter.
Capital City Trust's Sanofi position peaked at $9K in Q2 2013.
456 funds tracked by Wall St. Rank held Sanofi as of Q3 2013.

Based on Capital City Trust's 13F filing for Q3 2013, filed 12 Nov 2013.